Included in this edition are:

PMPRB Town Hall Meeting

• PMPRB Staff held a Town Hall meeting on October 1 at the Ottawa Convention Centre. Discussions involved PMPRB Staff taking a fresh look at the organization’s vision and mandate, potential new strategic priorities for the PMPRB and how to operationalize them moving forward. To help in the discussion and exercise, a distinguished panel of experts shared their unique perspectives on the Canadian pharmaceutical pricing and reimbursement environment.
• The Town Hall is part of a strategic planning process which will culminate in the presentation of a business plan to the PMPRB Board in the new year.

New Staff Members

• Jeffrey Biggs
• Brad Gash
• Branka Pejcic-Karapetrovic
• Parul Shah

Appeal Update: ratio-Salbutamol, ratiopharm and Sandoz

Voluntary Compliance Undertakings (VCUs):

• Lodalis, Valeant Canada Inc.

PMPRB appears before the Senate Standing Committee on National Finance

NPDUIS Update – 3 Upcoming Publications

• Generic Drug Prices in Canada 2013
• New Drug Pipeline Monitor (NDPM) – 6th edition
• Public Drug Plan Expenditure (PDPEx) Report: This is the 1st edition of an annual report detailing current trends in prescription drug expenditures in a select number of Canadian public drug plans.

Summary of September 18, 2014 Board Meeting

More details regarding the October 2014 NEWSletter can be found on the PMPRB website.